Skip to main content


What it measures:

Measures symptoms on three subscales (Shumaker et al, 1994): 1. Irritative 2. Stress 3. Obstructive/Discomfort Originally studied on community-dwelling women with urinary incontinence, but also used for women with lower urinary tract complaints, attending continence clinics, or on a surgical waiting list for urinary symptoms (Shumaker et al, 1994; Ross et al, 2006). Purpose: To study impact on urinary symptoms on quality of life and ability to participate in everyday activities (Shumaker et al, 1994; Ross et al, 2006). UDI-6 responses predicted whether stress UI, bladder outlet obstruction, and detrusor overactivity were found on urodynamic testing (Ross et al, 2006)

Target Population:

Women with urinary incontinence (UI) specific to lower urinary tract dysfunction and genital prolapse.

Developed to address a gap in UI literature and a lack of a UI-specific measure of health-related QOL.  In the original article, the UDI was intended to be used with the Incontinence Impact Questionnaire (Shumaker et al, 1994).

You Might Also Like...


Physical Therapy Management of Functional Constipation in Adults

Jul 1, 2022

This CPG describes the evidence for physical therapist interventions used in the conservative management of adults with functional constipation, a nonpathological

Test & Measure

3-Incontinence Questionnaire (3-IQ)

Self-administered brief questionnaire with purpose of differentiating between stress and urge urinary incontinence in women.

Test & Measure

Pelvic Floor Distress Inventory (PFDI-20)

Measures pelvic floor disorders.